- Home
- LDWY
LDWY
Lendway Inc. (DE)
as 11-15-2024 4:00pm EST
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two Industry Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.
| Founded: | 1990 | Country: | United States |
| Employees: | N/A | City: | MINNEAPOLIS |
| Market Cap: | 6.9M | IPO Year: | 1991 |
| Target Price: | N/A | AVG Volume (30 days): | 5.1K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.56 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.02 - $6.88 | Next Earning Date: | 11-29-2024 |
| Revenue: | $24,813,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Lendway Inc. (DE) News
LDWY Breaking Stock News: Dive into LDWY Ticker-Specific Updates for Smart Investing
ACCESSWIRE
3 months ago
Lendway, Inc. Announces Second Quarter 2024 Financial Results
ACCESSWIRE
5 months ago
Mark Jundt, Dan Philp to serve as Co-Chief Executive Officers of Lendway, Inc.
Yahoo Finance Video
5 months ago
FDA panel votes to recommend Eli Lilly's Alzheimer's drug
GlobeNewswire
5 months ago
Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis
Reuters
5 months ago
California seeks company profits in Big Oil climate lawsuit
USA TODAY
5 months ago
S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead
GlobeNewswire
5 months ago
Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis
Business Wire
5 months ago
Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock
Compare LDWY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LDWY Lendway Inc. (DE) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.